Related Experiment Video
Updated: Sep 25, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Care delivery and self-management strategies for children with epilepsy
Nigel Fleeman1, Peter M Bradley2, Mariangela Panebianco3
1Liverpool Reviews & Implementation Group, University of Liverpool, Liverpool, UK.
Insights
Specialized epilepsy interventions show varied benefits for children, with some reducing seizure frequency. However, methodological flaws limit conclusions, necessitating further research with robust trials for definitive evidence.
Area of Science:
- Neurology
- Pediatrics
- Evidence-Based Medicine
Background:
- Epilepsy is a neurological disorder characterized by abnormal brain electrical activity, impacting children and adults.
- Criticism regarding the long-term impact of pediatric epilepsy care has spurred the development of new service models.
- This review is an updated Cochrane Review examining interventions for childhood epilepsy.
Purpose of the Study:
- To assess the effectiveness of specialized epilepsy interventions compared to usual care for children and adolescents.
- To evaluate the impact of these interventions on children with epilepsy and their families.
Main Methods:
- Systematic search of multiple databases including Cochrane Register of Studies, MEDLINE, PsycINFO, CINAHL Plus, and clinical trial registries up to January 2020.
- Inclusion of randomized controlled trials (RCTs) involving children and adolescents with epilepsy.
- Independent selection of trials, data extraction, and quality assessment focusing on seizure frequency, medication, participant knowledge, quality of life, health status, psychosocial functioning, and costs.
Main Results:
- Nine studies evaluated eight interventions, including seven self-management programs and one new care model.
- Most programs showed some self-reported benefits for children with epilepsy, but all studies had methodological flaws.
- Moderate certainty evidence indicated one educational intervention reduced seizure frequency; low certainty evidence suggested others reduced seizure severity. Evidence for other outcomes was mixed.
Conclusions:
- While evaluated programs offered some benefits, their impact was highly variable, and no single program demonstrated consistent benefits across all outcomes.
- All included studies suffered from methodological limitations, preventing definitive conclusions.
- Insufficient evidence supports any single intervention; further RCTs with validated measures are required to establish clinical meaningfulness and statistical significance.
Background:
Epilepsy is a neurological disorder affecting both children and adults. Epileptic seizures are the result of excessive and abnormal cortical cell electrical activity in the brain. In response to criticism that epilepsy care for children has little impact on long-term outcomes, healthcare professionals and administrators have developed various service models and strategies to address perceived inadequacies. This is an updated version of a Cochrane Review previously published in 2018.
Objectives:
To assess the effects of any specialised or dedicated intervention for epilepsy versus usual care in children and adolescents with epilepsy and their families.
Search Methods:
We searched the following databases on 14 January 2020: the Cochrane Register of Studies (CRS Web), MEDLINE (Ovid, 1946 to 13 January 2020), PsycINFO (1887 to 14 January 2020), CINAHL Plus (1937 to 14 January 2020), ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform. The Cochrane Register of Studies (CRS Web) includes the Cochrane Epilepsy Group Specialised Register and the Cochrane Central Register of Controlled Trials (CENTRAL). We also contacted experts in the field seeking information on unpublished and ongoing studies and checked the websites of epilepsy organisations and the reference lists of included studies.
Selection Criteria:
We included randomised controlled trials recruiting children and adolescents with epilepsy.
Data Collection And Analysis:
Two review authors independently selected trials for inclusion and extracted the relevant data. We assessed the following outcomes: 1. Seizure frequency and severity; 2. Appropriateness and volume of medication prescribed (including evidence of drug toxicity); 3. Participants' reported knowledge of information and advice received from professionals; 4. Participants' reports of health and quality of life; 5. Objective measures of general health status; 6. Objective measures of social or psychological functioning (including the number of days spent on sick leave/absence from school or work, and employment status); and 7. Costs of care or treatment. The results of the data extraction and quality assessment for each study were presented in structured tables and as a narrative summary. All summary statistics were extracted for each outcome.
Main Results:
We included nine studies of eight interventions in the review, reporting on seven distinct self-management programmes for educating or counselling children with epilepsy and their parents, and one new model of care. Based largely on self-reported outcomes, each programme showed some benefits for the well-being of children with epilepsy; however, all of the included studies had methodological flaws. No single programme was evaluated with different study samples, and in no instance was the same outcome measured and reported in the same way across studies, precluding any possible meta-analysis, even if the interventions were considered sufficiently similar to include in meta-analysis. We chose the outcomes for which data might be important for decisions about the interventions as per guidance in the Cochrane Handbook for Systematic Reviews of Interventions. We found moderate certainty evidence that one of the educational interventions reduced seizure frequency. There was low certainty evidence that two other educational interventions reduced seizure severity, seizure control, and seizure cure rates. The evidence for all other outcomes (drug adherence, knowledge, self-efficacy and self-perception of epilepsy on quality of life) was mixed.
Authors' Conclusions:
Whilst each of the programmes evaluated in this review showed some benefit to children with epilepsy, their impact was extremely variable. No programme showed benefits across the full range of outcomes, and all studies had methodological problems. There is currently insufficient evidence in favour of any single programme. Further evidence from randomised controlled trials using validated measures and considering clinical meaningfulness as well as statistical significance of results is required.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Dysrhythmias VII: Nursing Management of Dysrhythmias
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Chronic Kidney Disease IV: Nursing Management